BRAF and colorectal cancer: BRAF wild-type was associated with a lower risk of colorectal cancer, multivariable hazard ratio; 0.73 (95% CI 0.64–0.83) whereas BRAF mutated tumors did not show a reduced risk of colorectal cancer (HR 1.03, 95% CI 0.76–1.38).